Magnesium pemoline: stimulant effects on performance of fatigued men. 1968

E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008297 Male Males
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D010389 Pemoline A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children. Phenoxazole,Phenylisohydantoin,Cylert,PemADD,Pemoline Compounds,Pemoline Magnesium,Tradon,Compounds, Pemoline,Magnesium, Pemoline
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011340 Problem Solving A learning situation involving more than one alternative from which a selection is made in order to attain a specific goal.
D011581 Psychological Tests Standardized tests designed to measure abilities (as in intelligence, aptitude, and achievement tests) or to evaluate personality traits. Parenting Stress Index,Trier Social Stress Test,Trier Stress Test,Psychologic Tests,Psychological Test,Test, Psychological,Tests, Psychological,Index, Parenting Stress,Psychologic Test,Stress Index, Parenting,Stress Test, Trier,Test, Psychologic,Test, Trier Stress,Trier Stress Tests
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005222 Mental Fatigue A condition of low alertness or cognitive impairment, usually associated with prolonged mental activities or stress. Brain Fog,Cognitive Exhaustion,Cognitive Weariness,Fatigue, Mental,Mental Fog,Cognitive Exhaustions,Cognitive Wearinesses,Exhaustion, Cognitive,Fog, Brain,Fog, Mental,Weariness, Cognitive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
October 1969, Archives internationales de pharmacodynamie et de therapie,
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
August 1967, Science (New York, N.Y.),
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
January 1972, Psychopharmacologia,
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
April 1969, Psychological reports,
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
February 1967, Science (New York, N.Y.),
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
January 1970, Behavioral neuropsychiatry,
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
January 1968, Psychopharmacologia,
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
September 1968, Current therapeutic research, clinical and experimental,
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
November 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
E W Herbert, and S Gelfand, and L D Clark, and D M Gelfand
January 1969, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!